KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Net Cash Flow (2017 - 2025)

Elanco Animal Health's Net Cash Flow history spans 9 years, with the latest figure at $26.0 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 52.73% year-over-year to $26.0 million; the TTM value through Dec 2025 reached $6.0 million, down 97.1%, while the annual FY2025 figure was $6.0 million, 97.1% down from the prior year.
  • Net Cash Flow for Q4 2025 was $26.0 million at Elanco Animal Health, up from -$35.0 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $193.0 million in Q4 2021 and bottomed at -$291.0 million in Q1 2022.
  • The 5-year median for Net Cash Flow is $18.5 million (2024), against an average of $5.9 million.
  • The largest annual shift saw Net Cash Flow plummeted 955.88% in 2022 before it soared 1220.0% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $193.0 million in 2021, then tumbled by 176.17% to -$147.0 million in 2022, then soared by 88.44% to -$17.0 million in 2023, then skyrocketed by 423.53% to $55.0 million in 2024, then plummeted by 52.73% to $26.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Net Cash Flow are $26.0 million (Q4 2025), -$35.0 million (Q3 2025), and $25.0 million (Q2 2025).